ABCL - AbCellera Biologics Inc.
IEX Last Trade
2.98
0.030 1.007%
Share volume: 49,447
Last Updated: Fri 27 Dec 2024 08:30:01 PM CET
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) :
0.90%
PREVIOUS CLOSE
CHG
CHG%
$2.95
0.03
1.02%
View ratios
| Fiscal Date | 2022-06-30 | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 | 2024-03-31 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q2 2022 | Q3 2022 | Q4 2022 | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | Q1 2024 | |
| Report Date | 2022-08-09 | 2022-11-08 | 2023-02-21 | 2023-05-04 | 2023-08-03 | 2023-11-02 | 2024-02-20 | 2024-05-07 | |
| Total revenue | 45.917 M | 101.383 M | 21.543 M | 12.192 M | 10.056 M | 6.599 M | 9.178 M | 9.954 M | |
| Cost of revenue | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Gross profit | 45.917 M | 101.383 M | 21.543 M | 12.192 M | 10.056 M | 6.599 M | 9.178 M | 9.954 M | |
| 120.80% | -78.75% | -43.41% | -17.52% | -34.38% | 39.08% | 8.46% | |||
| Operating expenses | 44.217 M | 43.463 M | 43.950 M | 71.552 M | 55.835 M | 55.754 M | 67.696 M | 60.004 M | |
| Selling general and admin | 17.532 M | 16.881 M | 15.704 M | 18.905 M | 19.362 M | 17.837 M | 19.075 M | 20.717 M | |
| Research and development | 26.685 M | 26.582 M | 28.246 M | 52.647 M | 36.473 M | 37.917 M | 48.621 M | 39.287 M | |
| Total expenses | 54.313 M | 63.648 M | 59.321 M | 77.066 M | 61.445 M | 61.489 M | 75.232 M | 64.848 M | |
| 17.19% | -6.80% | 29.91% | -20.27% | 0.07% | 22.35% | -13.80% | |||
| Operating income | -8.396 M | 37.735 M | -37.778 M | -64.874 M | -51.389 M | -54.890 M | -66.054 M | -54.894 M | |
| Ebit | -8.396 M | 37.735 M | -37.778 M | -64.874 M | -51.389 M | -54.890 M | -66.054 M | -54.894 M | |
| Pretax income | -6.886 M | 46.587 M | -31.411 M | -48.148 M | -38.004 M | -39.276 M | -48.601 M | -42.747 M | |
| -776.55% | -167.42% | 53.28% | -21.07% | 3.35% | 23.74% | -12.05% | |||
| Income tax | -101.000 K | 19.963 M | -1.518 M | -8.038 M | -7.476 M | -10.666 M | -1.451 M | -2.137 M | |
| Net income basic | -6.785 M | 26.624 M | -29.893 M | -40.110 M | -30.528 M | -28.610 M | -47.150 M | -40.610 M | |
| 492.39% | -212.28% | -34.18% | 23.89% | 6.28% | -64.80% | 13.87% | |||
| Net income | -6.785 M | 26.624 M | -29.893 M | -40.110 M | -30.528 M | -28.610 M | -47.150 M | -40.610 M | |
| 492.39% | -212.28% | -34.18% | 23.89% | 6.28% | -64.80% | 13.87% |